ADA: Elevated BMI in Adolescence Linked to T1D in Young Adulthood
MONDAY, June 6, 2022 (HealthDay News) — Elevated body mass index (BMI) in adolescence is associated with an increased risk for type 1 diabetes in young adulthood, according to a study published online June 5 in Diabetologia to coincide with the annua…
Learn MoreADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
MONDAY, June 6, 2022 (HealthDay News) — An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new o…
Learn MoreBridge Therapy Between Induction, ASCT May Slow Neuroblastoma
MONDAY, June 6, 2022 (HealthDay News) — For patients with high-risk neuroblastoma with end-induction stable metastatic disease, postinduction bridge therapy before autologous stem cell transplantation (ASCT) is associated with better outcomes, accord…
Learn MoreSuicidal Ideation, Attempts Up in Transgender, Sexual-Minority Teens
MONDAY, June 6, 2022 (HealthDay News) — Transgender and sexual-minority adolescents have an increased risk for suicidal ideation and attempt compared with their cisgender and heterosexual peers, according to a study published online June 6 in CMAJ, t…
Learn MoreNew Weight-Loss Drug Looks Good in Trial
MONDAY, June 6, 2022 (HealthDay News) — A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too.Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are…
Learn MoreASCO: Increase in Cancer-Related Death Seen During Pandemic
MONDAY, June 6, 2022 (HealthDay News) — From 2019 to 2020, there was an increase of 3.2 percent in cancer-related deaths, which was higher than the number of projected deaths, according to a study presented at the annual meeting of the American Socie…
Learn MoreAE Risk Examined for Abiraterone, Enzalutamide in Prostate Cancer
MONDAY, June 6, 2022 (HealthDay News) — For men with advanced prostate cancer, receipt of abiraterone or enzalutamide is associated with an increased risk for major metabolic or cardiovascular adverse events, according to a study published online Apr…
Learn MoreRadiation Segmentectomy Efficacious for Unresectable Liver Cancer
MONDAY, June 6, 2022 (HealthDay News) — For patients with unresectable very early to early-stage hepatocellular carcinoma with suboptimal location for ablation, radiation segmentectomy is efficacious with few high-grade adverse events, according to a…
Learn MoreMetformin Does Not Improve Survival in High-Risk Breast Cancer
MONDAY, June 6, 2022 (HealthDay News) — For patients with high-risk nonmetastatic breast cancer receiving standard therapy, the addition of metformin does not improve invasive disease-free survival, according to a study published in the May 24/31 iss…
Learn MoreAmerican Psychiatric Association, May 21-25
The annual meeting of the American Psychiatric Association was held from May 21 to 25 in New Orleans and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in psychiatr…
Learn More